Solutions / Corporations
Pharma & Biotech Corporations
Access deep healthcare data & drug research
Bloomberg has been a global leader in healthcare data for over a decade, integrating data from more than a dozen leading providers into powerful tools and solutions that empower your company’s strategists, business development and competitive intelligence executives to make more informed decisions.
Specialized
Save time with instant access to analyst-curated, pharma-specific data, deep industry and disease research, and analytical and forecasting tools – all in one place.
Proprietary
Learn from research and content from Bloomberg’s pharma experts, and benchmark against disease hubs, models and forecasts that you can’t get anywhere else.
Actionable
Get the news, data, forecasts and opinions you need to assess markets, value assets, analyze targets and benchmark deals.
Exhaustive insights
Bloomberg gives you access to curated clinical trial and drug pipeline data across 5,000+ private and public company drug portfolios, along with revenue forecasts, drug-specific event catalyst calendars, and insights on prescriptions, patents, licensing, regulation, liability litigation and more.
Trusted disease hubs
Bloomberg Intelligence’s team of experienced biotech, pharma, policy and litigation analysts author exclusive, data-driven research that can help you pinpoint long-term market opportunities. Each analyst can be contacted through the Bloomberg Terminal, where you can dig deeper into the proprietary disease models on which their outlooks are based.
Hear a BI analyst explain how recent advances in treatment will transform the market for Alzheimer’s drugs.
Monitor the competition
Bloomberg’s financial data, news and analytics empower pharma corporations with macro-level insights across geopolitics, economics and financial markets. Track news on your company, competitors and industry, analyze revenues, income sources and patents, and use our AI-enhanced tools to search millions of public documents and transcripts in seconds.
Download the latest BI Disease Outlooks
Multiple Myeloma
Alzheimer's
Melanoma
Analyze company financials
Explore deep estimates and financial models specifically tailored to the pharma industry, with access to:
- Top-down models with patient funnels
- Peak sales & NPV estimates
- Pipeline drug revenue projections
- Regional rebate & reimbursement mix
- Cost of capital & credit profiles
- Automated valuation Excel templates
